VALIDATE One Health Seminar One: Inequitable Access to Medicines and Health Technologies in a One Health Context
https://www.youtube.com/embed/Xac6xPOc3hk?si=-Ed8hve9-D5zzJXc
In September 2023, members of the VALIDATE network and subject matter experts from around the world convened in Paarl, South Africa, to explore the application of the One Health model in the development of vaccines for Tuberculosis (TB) and Leishmaniasis. The One Health model was an interdisciplinary approach that acknowledged the interrelationships between human health, animal health, and environmental health.
During the workshop, valuable presentations were delivered by VALIDATE members, and we were pleased to share these insights with the broader VALIDATE Community with a series of Online Seminars.
Seminar One took place on Zoom, 15 November 2023, 15:00 GMT.
- How to Win at Hide and Seek: Utilizing Omic Approaches to Identify and Target Neglected Pathogens by Dr. Richard Burchmore, University of Glasgow.
In the talk, Richard will outline the opportunities and limitations of Omic approaches and give some examples of how they can be applied in the diagnosis and control of NTDs.
- Unforeseen Ramifications of Antimicrobial Usage: A Case Study on Antimony by Dr. Maria Adelaida Gomez, CIDIEM.
In this talk, Adelaida will reflect on the unexpected impacts of antileishmanial use in the context of water pollution and cultural practices in endemic populations. This will lead the way to discussing challenges and opportunities for control of leishmaniasis, under the umbrella of human, animal and environmental health.
About the Speakers
Dr Richard Burchmore is the Head of Proteomics & Senior Lecturer in Parasitology, University of Glasgow, UK.
Richard has been a leishmaniac since his undergraduate research project back in 1988. His research primarily centers around host: pathogen interactions, with a special emphasis on the role of parasite nutrient transporters. A significant portion of Richard’s work involves leveraging mass spectrometry for proteomic and metabolomic analyses.
Dr Maria Adelaida Gomez is a Scientist and Coordinator at CIDEIM in Colombia.
Adelaida focuses on investigating host-pathogen interactions and mechanisms impacting the clinical and therapeutic outcomes of human infections with intracellular protozoan parasites. Her work on cutaneous leishmaniasis informs translational research in intracellular and neglected infectious diseases and the development of tools for therapeutic evaluation and host immunomodulation.
